May 27, 2024Epilepsia OpenOpen Access

Treatment simplification to optimize cenobamate effectiveness and tolerability: A real‐world retrospective study in Spain

View Full Paper

Ask AI

Bookmark

Authors

JRJ. Rodríguez-UrangaAvanzare (Spain)JSJuan María Sánchez‐Caro RRRoshan Hariramani RamchandaniFundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla

Discussion

Member takes

Implication

Retrospective observational study demonstrates co-medication simplification in drug-resistant epilepsy, indicating sustained cenobamate effectiveness with improved tolerability.

Key Points

Seizure frequency dropped significantly following adjunctive cenobamate therapy, while defined daily dose of concurrent antiseizure medication decreased from 3.6 to 1.4.
Seizure-free status was achieved by 33.3% of patients at the final visit, while 85.7% responded with substantial seizure reductions on adjunctive cenobamate.
Retrospective observational study of focal-onset seizures reveals that tapering sodium channel blockers supports rational polytherapy without compromising seizure control.

Cite This Study

Rodríguez-Uranga et al. (2024) studied this question.

synapsesocial.com/papers/68e6836bb6db64358760c1b9 https://doi.org/10.1002/epi4.12959

View Full Paper

Ask AI

Bookmark

Implication

Retrospective observational study demonstrates co-medication simplification in drug-resistant epilepsy, indicating sustained cenobamate effectiveness with improved tolerability.

Treatment simplification to optimize cenobamate effectiveness and tolerability: A real‐world retrospective study in Spain

Discussion

Member takes

Implication

Key Points

Cite This Study

Treatment simplification to optimize cenobamate effectiveness and tolerability: A real‐world retrospective study in Spain

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider